Position in TMO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$633,719
-$193,525 QoQ
Shares Held
1,264
-24.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,642
of 2,606 holders
Holding Since
Sep 2020
20 quarters on record
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Global Investments holds $1,726,896 across 4 Diagnostics & Research names. TMO ranks #1 (36.7% of the industry book) .
All Filings in TMO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,719 | 1,264 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $827,244 | 1,683 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,076,038 | 1,857 | Shares | Sole | 2026-02-18 | |
| 2024-09-30 | $274,026 | 443 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $245,532 | 444 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $351,050 | 604 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $718,158 | 1,353 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $704,588 | 1,392 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $568,185 | 1,089 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $629,396 | 1,092 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $445,508 | 809 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $405,752 | 800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $430,821 | 793 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $479,017 | 811 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $411,687 | 617 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $338,227 | 592 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $296,628 | 588 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $323,573 | 709 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $277,604 | 596 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $216,786 | 491 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||